skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:039462/0247   Pages: 7
Recorded: 07/26/2016
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 14
1
Patent #:
NONE
Issue Dt:
Application #:
12166686
Filing Dt:
07/02/2008
Publication #:
US20090022814
Pub Dt:
01/22/2009
Title:
CANCER TREATMENT METHOD
2
Patent #:
NONE
Issue Dt:
Application #:
12496867
Filing Dt:
07/02/2009
Publication #:
US20100004302
Pub Dt:
01/07/2010
Title:
Methods for Treating Degenerative Diseases/Injuries
3
Patent #:
NONE
Issue Dt:
Application #:
12527220
Filing Dt:
08/14/2009
Publication #:
US20100075928
Pub Dt:
03/25/2010
Title:
CANCER TREATMENT METHOD
4
Patent #:
NONE
Issue Dt:
Application #:
12948159
Filing Dt:
11/17/2010
Publication #:
US20110129550
Pub Dt:
06/02/2011
Title:
CANCER TREATMENT METHOD
5
Patent #:
NONE
Issue Dt:
Application #:
13124182
Filing Dt:
08/09/2011
Publication #:
US20120149749
Pub Dt:
06/14/2012
Title:
METHOD OF TREATING THROMBOCYTOPENIA
6
Patent #:
NONE
Issue Dt:
Application #:
13146493
Filing Dt:
07/27/2011
Publication #:
US20110288142
Pub Dt:
11/24/2011
Title:
CRYSTALLINE N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
7
Patent #:
NONE
Issue Dt:
Application #:
13334770
Filing Dt:
12/22/2011
Publication #:
US20120189576
Pub Dt:
07/26/2012
Title:
3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
8
Patent #:
NONE
Issue Dt:
Application #:
13497576
Filing Dt:
07/17/2012
Publication #:
US20120322817
Pub Dt:
12/20/2012
Title:
COMBINATION
9
Patent #:
NONE
Issue Dt:
Application #:
13497580
Filing Dt:
07/27/2012
Publication #:
US20120283278
Pub Dt:
11/08/2012
Title:
COMBINATION
10
Patent #:
NONE
Issue Dt:
Application #:
13509955
Filing Dt:
07/27/2012
Publication #:
US20120283279
Pub Dt:
11/08/2012
Title:
COMBINATION
11
Patent #:
NONE
Issue Dt:
Application #:
13699103
Filing Dt:
11/20/2012
Publication #:
US20130237554
Pub Dt:
09/12/2013
Title:
COMBINATION
12
Patent #:
NONE
Issue Dt:
Application #:
13749047
Filing Dt:
01/24/2013
Publication #:
US20130137736
Pub Dt:
05/30/2013
Title:
Methods for Treating Degenerative Diseases/Injuries
13
Patent #:
NONE
Issue Dt:
Application #:
13906591
Filing Dt:
05/31/2013
Publication #:
US20140038982
Pub Dt:
02/06/2014
Title:
CANCER TREATMENT METHOD
14
Patent #:
NONE
Issue Dt:
Application #:
14083617
Filing Dt:
11/19/2013
Publication #:
US20140073679
Pub Dt:
03/13/2014
Title:
CRYSTALLINE N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
Assignor
1
NOVARTIS PHARMA AG
Exec Dt:
03/02/2015
Assignee
1
NOVARTIS AG
LICHTSTRASSE 35
BASEL, SWITZERLAND BASEL
Correspondence name and address
CPA GLOBAL LTD
LIBERATION HOUSE
CASTLE STREET
ST HELIER, JE1 1BL JERSEY

Search Results as of: 06/21/2024 11:15 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT